Factors associated with utilization of healthcare resources among epilepsy patients

Epilepsy Research

Volumn 79, Issue 2-3, 2008, Pages 120-129

  Bautista, Ramon Edmundo D ^a   Tannahill Glen, E ^a   Wludyka, Peter S ^a   Shetty, Namrata K ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

Author keywords

Cost of care; Epilepsy; Quality of life; Resource utilization; Seizure frequency

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; EDUCATIONAL STATUS; EMERGENCY WARD; EPILEPSY; ETHNICITY; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; INCOME; INSURANCE; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RACE DIFFERENCE; SCORING SYSTEM; SEIZURE; SEX DIFFERENCE; UNIVARIATE ANALYSIS;

ADULT; AMBULATORY CARE; ANTICONVULSANTS; DATA INTERPRETATION, STATISTICAL; DRUG UTILIZATION; EPILEPSY; FEMALE; HEALTH RESOURCES; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; SEX FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 42749092098     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.01.003     Document Type: Article

References (28)

1. Begley C.E., Famulari M., Annegers J.F., Lairson D.R., Reynolds T.F., Coan S., Dubinsky S., Newmark M.E., Leibson C., So E.L., and Rocca W.A. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 41 3 (2000) 342-351
2. Begley C.E., Lairson D.R., Reynolds T.F., and Coan S. Early treatment cost in epilepsy and how it varies with seizure type and frequency. Epilepsy Res. 47 (2001) 205-215
3. Begley C.E., Beghi E., Beran R.G., Heaney D., Langfitt J.T., Pachlatko C., Silfvenius H., Sperling M.R., and Wiebe S. ILAE commission on the burden of epilepsy, subcommission on the economic burden of epilepsy: final report 1998-2001. Epilepsia 43 6 (2002) 668-673
4. Birbeck G.L., Hays R.D., Cui X., and Vickrey B.G. Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 43 5 (2002) 535-538
5. Burneo J.G., Black L., Knowlton R.C., Faught E., Morawetz R., and Kuzniecky R.I. Racial disparities in the use of surgical treatment for intractable temporal lobe epilepsy. Neurology 64 1 (2005) 50-54
6. Christiensen J., Kjeldsen M.J., Andersen H., Friis M.L., and Sidenius P. Gender differences in epilepsy. Epilepsia 46 6 (2005) 956-960
7. Cramer J.A., Perrine K., Devinsky O., and Meador K. A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10. Epilepsia 37 6 (1996) 577-582
8. Cramer J.A., Blum D., Fanning K., Reed M., and for the Epilepsy Impact Project Group. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav. 5 (2005) 337-342
9. Devinsky O., Vickrey B.G., Cramer J., Perrine K., Hermann B., Meador K., and Hays R.D. Development of the quality of life in epilepsy inventory. Epilepsia 36 11 (1995) 1089-1104
10. Duchowny M.S., Harvey A.S., Sperling M.S., and Williamson P.D. Indications and criteria for surgical intervention. In: Engel J., and Pedley T.A. (Eds). Epilepsy: A Comprehensive Textbook (1997), Lippincott-Raven Publishers, Philadelphia 1677-1685
11. Falip M., Artazcoz L., de la Pena P., Perez-Sempere A., Martin-Moro M., and Codina M. Classic antiepileptic and new generation antiepileptic drugs: gender differences in effectiveness and adverse drug reactions. Neurologia 20 2 (2005) 71-76
12. French J.A. Refractory epilepsy: clinical overview. Epilepsia 48 Suppl. 1 (2007) 3-7
13. Frye M.A., Calabrese J.R., Reed M.L., Wagner K.D., Lewis L., McNulty J., and Hirschfeld R.M. Use of health care services among persons who screen positive for bipolar disorder. Psychiatr. Serv. 56 12 (2005) 1529-1533
14. Gilliam F.G., Barry J.J., Hermann B.P., Meador K.J., Vahle V., and Kanner A.M. Rapid detection of major depression in epilepsy: a multicenter study. Lancet Neurol. 5 5 (2006) 399-405
15. Holden E.W., Thanh Nguyen H., Grossman E., Robinson S., Nelson L.S., Gunter M.J., Von Worley A., and Thurman D.J. Estimating prevalence, incidence, and disease-related mortality for patients with epilepsy in managed care organizations. Epilepsia 46 2 (2005) 311-319
16. Johnson E.K., Jones J.E., Seidenberg M., and Hermann B.P. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 45 5 (2004) 544-550
17. Kobau R., Gilliam F., and Thurman D.J. Prevalence of self-reported epilepsy or seizure disorder and its association with self-reported depression and anxiety: results from the 2004 HealthStyles Survey. Epilepsia 47 11 (2006) 1915-1921
18. Kotsopoulos I.A., Evers S.M., Ament A.J., Kessels F.G., de Krom M.C., Twellaar M., Metsemakers J.F., and Knottnerus A.J. The costs of epilepsy in three different populations of patients with epilepsy. Epilepsy Res. 54 (2003) 131-140
19. Langfitt J.T., Holloway R.G., McDermott M.P., Messing S., Sarosky K., Berg A.T., Spencer S.S., Vickrey B.G., Sperling M.R., Bazil C.W., and Shinnar S. Health care costs decline after successful epilepsy surgery. Neurology 68 (2007) 1290-1298
20. Loring D.W., Meador K.J., and Lee G.P. Determinants of quality of life in epilepsy. Epilepsy Behav. 5 (2005) 976-980
21. Murray M.I., Halpern M.T., and Leppik I.E. Costs of refractory epilepsy in adults in the USA. Epilepsy Res. 23 (1996) 139-148
22. Platt M., and Sperling M.R. A comparison of surgical and medical coss for refractory epilepsy. Epilepsia 43 Suppl. 4 (2002) 25-31
23. Pulsipher D.T., Seidenberg M., Jones J., and Hermann B. Quality of life and comorbid medical and psychiatric conditions in temporal lobe epilepsy. Epilepsy Behav. 9 3 (2006) 510-514
24. SANAD Study Group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblended randomized control trial. Lancet 369 (2007) 1000-1015
25. Semah F., Picot M.C., Derambure P., Dupont S., Vercueil L., Chassagnon S., Marchal C., Thomas P., and Ryvlin P. The choice of antiepileptic drugs in newly diagnosed epilepsy: a national French survey. Epileptic Disord. 6 4 (2004) 255-265
26. Tracy J.I., Dechant V., Sperling M.R., Cho R., and Glosser D. The association of mood with quality of life ratings in epilepsy. Neurology 68 14 (2006) 1101-1107
27. Van Hout B., Gagnon D., and Souetre E. Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom. Epilepsia 38 11 (1997) 1221-1226
28. Wilby J., Kainth A., Hawkins N., Epstein D., McIntosh H., McDaid C., Mason A., Golder S., O'Meara S., Sculpher M., Drummond M., and Forbes C. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systemic review and economic evaluation. Health Technol. Assess. 9 15 (2005) 1-157